Clinical Trial Update: Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject

View source ↗

Summary

Expanded access update describing treatment with allogeneic bone-marrow derived human mesenchymal stem cells (Allo-hMSC) for a single Parkinson disease patient;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Allo-hMSC (bone marrow-derived human mesenchymal stem cells)

Snippet

Sponsor: Mya Schiess | Conditions: Parkinson Disease | Status: NO_LONGER_AVAILABLE